Bio-Rad Laboratories BIO
NYSE BIO
$378.67 -0.88 (-0.23%)
As of: Sep 30, 2026 · 1:21 PM EDT

Bio-Rad Laboratories, Inc. (BIO) EV to EBITDA (2010 - 2017)

Updated

Bio-Rad Laboratories' (BIO) EV to EBITDA was 25.59 for Q3 2017, up 56.2% from 16.38 a year earlier but down 5.6% from the prior quarter.

Analysis

Bio-Rad Laboratories, Inc. (BIO) EV to EBITDA (2010 - 2017) Analysis & Trends

Over the twelve months ended Sep 30, 2017, Bio-Rad Laboratories' EV to EBITDA came in at 15.93, up 131.8% year-over-year.

  • Five-year quarterly EV to EBITDA spans a low of 6.61 in Q2 2013 and a high of 27.11 in Q2 2017.
  • Year over year, EV to EBITDA has now increased in each of the last three quarters, with growth averaging 48.4% over the last six quarters.
  • The year-over-year growth in EV to EBITDA has ranged between 5.6% (Q2 2016) and 104.2% (Q2 2017) over the last five years.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 25.59
Jun 30, 2017 27.11
Mar 31, 2017 21.80
Sep 30, 2016 16.38
Jun 30, 2016 13.28
Mar 31, 2016 12.55
Sep 30, 2015 11.43
Jun 30, 2015 12.58
Mar 31, 2015 11.69
Sep 30, 2014 9.37
Jun 30, 2014 9.58
Mar 31, 2014 10.92
Sep 30, 2013 8.77
Jun 30, 2013 6.61
Mar 31, 2013 7.73
Sep 30, 2012 5.54
Jun 30, 2012 5.08
Mar 31, 2012 5.54
Sep 30, 2011 4.12
Jun 30, 2011 6.34
API Access

Bio-Rad Laboratories, Inc. EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=BIO&period=max&api_key=YOUR_API_KEY